Global Cause
Clinical Trials Q4 2023
-
Tackling common disease burden through clinical trial innovation
Clinical trials are the difference between treating with hope and treating with knowledge. With an explosion in therapeutic opportunities — personalised cancer vaccines, gene-editing for lifelong cholesterol reduction, annual injections to lower blood pressure and novel therapies to prevent the onset of dementia — clinical trials are essential to establish whether what looks good in...
-
Good Trials Prism: collaboration to bolster clinical trials in LMICs
In August 2023, the Good Clinical Trials Collaborative (the Collaborative) and four major research networks unveiled a strategic partnership to bolster clinical trials research in low and middle-income countries (LMICs). With ADVANcing Clinical Evidence in Infectious Diseases, Africa Health Research Institute, Oxford University Clinical Research Unit in Vietnam and The Global Health Network — the Wellcome-funded...
-
Breaking down the barriers of academic multinational trials
In Europe, almost half of clinical trials are carried out by academics in University Hospitals and other public organisations. While most industry-sponsored trials are multinational, the vast majority of investigator-initiated trials are conducted in a single country. Even though some academics develop solutions with novel treatments, diagnostics or vaccines, their work often focuses on comparative...
-
Ways to strengthen the clinical research ecosystem in resource-limited settings
Encouraging clinical research in low-income settings is essential to tap into opportunities that can make a difference in patients’ lives. Creating a sustainable clinical research ecosystem requires open and close collaboration. The pharmaceutical industry is a crucial contributor to this ecosystem in designing, initiating and running global clinical trials according to the highest regulatory and...
-
s Sponsored
Streamlining clinical trials: overcoming the diagnostics challenge
As clinical trials become decentralised/hybrid with people increasingly taking part from home, a major challenge remains collecting samples for diagnostic testing. Monitoring participants’ vital signs via wearable technology is becoming commonplace in clinical trials. Yet, the collection and analysis of diagnostics remains a logistical challenge. On-site tests require participants to visit a trial site —...